Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI

Recruiting

I'm Interested

Trial ID: NCT02893293

Age - 8 Years-40 Years Gender - All Accepting Healthy Volunteers - No

Purpose

The goal of the project is to evaluate osteonecrosis before and after decompression surgery with ferumoxytol-enhanced MRI.

Official Title

Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI

Stanford Investigator(s)

Heike Daldrup-Link
Heike Daldrup-Link

Professor of Radiology (General Radiology) and, by courtesy, of Pediatrics (Hematology/Oncology)

Eligibility


Inclusion Criteria:

   - Osteonecrosis

   - planned decompression surgery with autologous stem cell transplant

Exclusion Criteria:

   - Contraindications for magnetic resonance imaging

   - Hemosiderosis/hemochromatosis ( patients can still be included in the non-ferumoxytol
   arm)

View More
View Less

Intervention(s):

drug: Ferumoxytol-enhanced magnetic resonance imaging

device: Magentic Resonance Imaging

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Anne Sawyer
650-302-2846

©2024 Stanford Medicine